CN Patent

CN120916776A — 用于眼表疾病患者的眼部手术准备的眼用组合物

Assigned to Novaliq GmbH · Expires 2025-11-07 · 1y expired

What this patent protects

本公开文本提供了用于(a)使患者为眼部手术做准备，(b)治疗为眼部手术做准备的患者的眼表疾病，和(c)为准备眼部手术而执行生物测量学测量的方法，其中所述方法包括每天一次至四次向所述患者的眼睛局部施用包含溶解于任选地具有醇助溶剂的半氟化烷烃中的约0.05%‑0.1%（w/v）环孢菌素的组合物。

USPTO Abstract

本公开文本提供了用于(a)使患者为眼部手术做准备，(b)治疗为眼部手术做准备的患者的眼表疾病，和(c)为准备眼部手术而执行生物测量学测量的方法，其中所述方法包括每天一次至四次向所述患者的眼睛局部施用包含溶解于任选地具有醇助溶剂的半氟化烷烃中的约0.05%‑0.1%（w/v）环孢菌素的组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN120916776A
Jurisdiction
CN
Classification
—
Expires
2025-11-07
Drug substance claim
No
Drug product claim
No
Assignee
Novaliq GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.